Regeneron Pharmaceuticals
REGN
#294
Rank
A$101.01 B
Marketcap
$923.98
Share price
0.40%
Change (1 day)
-34.29%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): A$7.20 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$14.20 Billion. , an increase over its 2023 earnings that were of A$6.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 A$7.51 B13.83%
2023 A$6.60 B-13.57%
2022 A$7.63 B-47.9%
2021 A$14.65 B144.75%
2020 A$5.98 B56.86%
2019 A$3.81 B-4.87%
2018 A$4.01 B22.86%
2017 A$3.26 B56.3%
2016 A$2.09 B8.55%
2015 A$1.92 B54.53%
2014 A$1.24 B11.14%
2013 A$1.12 B72.13%
2012 A$0.65 B-285.93%
2011 -A$0.36 Billion121.73%
2010 -A$0.16 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.14 Billion-25.02%
2007 -A$0.18 Billion6.32%
2006 -A$0.17 Billion-186.52%
2005 A$0.19 B2103.7%
2004 A$8.87 M-105.66%
2003 -A$0.16 Billion-18.18%
2002 -A$0.2 Billion42.33%
2001 -A$0.14 Billion129.35%
2000 -A$58.73 Million51.87%
1999 -A$38.67 Million92.19%
1998 -A$20.12 Million66.23%
1997 -A$12.11 Million-55.49%
1996 -A$27.2 Million103.53%
1995 -A$13.37 Million-70.89%
1994 -A$45.9 Million-26.08%
1993 -A$62.09 Million114.67%
1992 -A$28.93 Million196.77%
1991 -A$9.75 Million87.88%
1990 -A$5.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.24 B-3.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.99 B-60.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.41 B 264.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.43 B 185.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$12.48 B 66.15%๐Ÿ‡ซ๐Ÿ‡ท France